MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Venus Concept DPO Ratio 2011-2025 | VERO
Annual DPO Ratio Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 138 | 129 | 89.6 | 85.3 | 86.7 | 102 | 112 | 61.4 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 138 | 61.4 | 100 |
Quarterly DPO Ratio Venus Concept
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119 | 96.3 | 129 | - | 128 | 144 | 132 | - | 129 | 123 | 104 | - | 57.4 | 49.8 | 51.2 | - | 65.6 | 75.9 | 77.2 | - | 80.4 | 113 | 137 | - | 68.8 | 59.5 | 56.1 | - | 133 | 138 | 83.9 | - | 75.4 | 53.5 | 55.9 | - | 33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 144 | 33 | 91.8 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
76.2 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.84 | -0.65 % | $ 133 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 304.89 | -1.05 % | $ 8.6 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
InMode Ltd.
INMD
|
65.1 | $ 14.38 | -0.9 % | $ 1.14 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 0.96 | 4.68 % | $ 15.5 M | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 96.85 | 0.64 % | $ 1.23 B | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 45.3 | 0.38 % | $ 6.75 K | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
82.8 | $ 128.53 | 2.45 % | $ 224 B | USA |
 |
Boston Scientific Corporation
BSX
|
66 | $ 91.99 | -0.64 % | $ 135 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
71.8 | $ 62.62 | -0.21 % | $ 3.4 B |  Britain |
 |
LENSAR
LNSR
|
66 | $ 11.61 | 0.87 % | $ 134 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.11 | 7.99 % | $ 116 M |  France |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
PAVmed
PAVM
|
128 | $ 0.32 | -3.88 % | $ 2.31 M | USA |
|
Cognyte Software Ltd.
CGNT
|
81.1 | $ 9.66 | -2.03 % | $ 694 M | Israel |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
31.3 | $ 7.45 | -1.46 % | $ 280 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 163.97 | -0.89 % | $ 12.3 B | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 1.06 | - | $ 109 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.8 | $ 12.55 | -1.26 % | $ 339 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 14.81 | 0.41 % | $ 97.1 M | USA |
 |
AxoGen
AXGN
|
79.6 | $ 29.79 | -1.96 % | $ 1.32 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
CONMED Corporation
CNMD
|
60.6 | $ 39.86 | -2.38 % | $ 1.23 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
70.1 | $ 17.71 | 0.62 % | $ 409 M | USA |
 |
Globus Medical
GMED
|
23.2 | $ 86.17 | -0.61 % | $ 11.7 B | USA |
 |
Sensus Healthcare
SRTS
|
14.7 | $ 3.67 | -4.18 % | $ 59.9 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 13.54 | 0.86 % | $ 1.04 B | USA |